Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid increases hair count in men with hair loss.

Female hair loss linked to metabolic syndrome, not in males.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

A male with aromatase deficiency improved bone health with estradiol treatment.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Barley extract, specifically procyanidin B-3, can promote hair growth and counteract growth inhibition.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Losartan can cause temporary loss of taste.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Type I interferons play a key role in the development of various skin diseases.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.